• Personalized immunosuppression and minimization: where are we now and what is on the horizon

  • Personalized immunosuppression and minimization: where are we now and what is on the horizon

  • Personalized immunosuppression and minimization: where are we now and what is on the horizon

  • Personalized immunosuppression and minimization: where are we now and what is on the horizon

  • Personalized immunosuppression and minimization: where are we now and what is on the horizon

  • Personalized immunosuppression and minimization: where are we now and what is on the horizon

#Immunosuppression #North America

Live Session:

Wednesday, July 14, 2021 - 4:00 PM (Local time in New York)
Local time (Corresponding local time at your current location)

Register

Faculty:


Personalized immunosuppression dosing algorithms


Marith Francke

Erasmus MC, University Medical Center Rotterdam
Department of Internal Medicine
Division of Nephrology and Transplantation
The Netherlands 

Marith Francke (1997) is a Ph.D. student at the department of internal medicine, division of nephrology and transplantation at the Erasmus MC, University Medical Center Rotterdam, the Netherlands. In 2015 she started her Bachelors in Medicine, followed by a research master in Clinical research. Currently, she is employed as a Ph.D. student. Her research focuses on the optimization of immunosuppressive therapy after kidney transplantation. She works on strategies to improve tacrolimus treatment and she tries to explain variability in the pharmacokinetics of the drug and to use dosing algorithms for tacrolimus to predict an individual’s dose requirement. The overarching aim is to further personalize tacrolimus treatment after transplantation.

An overarching approach to personalized immunosuppression


David Axelrod

Professor of Surgery
Surgical Director of Kidney, Pancreas, and Living Donor Transplantation Fellowship Director
University of Iowa
Iowa City, USA

Dr. Axelrod is currently Professor of Surgery at the University of Iowa. He serves as the Surgical Director of Kidney, Pancreas, and Living Donor Transplantation and fellowship director.  He previously was Section Chief of Solid Organ Transplantation at Dartmouth Hitchcock Medical Center from 2005-16.  In addition, he was a member of the clinical staff at Massachusetts General Hospital and subsequently at Lahey Hospital.  His clinical interests include the surgical management of end-stage kidney and liver disease including treatment of hepatocellular carcinoma and portal hypertension.

His research interests including surgical outcomes analysis including economic evaluation, Markov modeling, and statistical process control techniques. Previous investigations have examined the economic impact of MELD on liver transplantation, quality outcome monitoring in organ transplantation, steroid-free immunosuppression in kidney and pancreas transplants, and geographic disparities in access to organ transplant.  

Schedule (90 min):


  • 05 min

    Welcome and introduction by the Chairs

  • 25 min

    Presentation: Personalized immunosuppression dosing algorithms, Marith Francke, The Netherlands

  • 05 min

    Live Q&A with Marith Francke, The Netherlands

  • 25 min

    Presentation: An overarching approach to personalized immunosuppression, David Axelrod, USA

  • 05 min

    Live Q&A with David Axelrod, USA

  • 20 min

    Interactive panel discussion with audience participation led by the Chairs

  • 05 min

    Masterclass closing remarks

Join Our Mailing List


Invalid Input
Invalid Input
Invalid email address

Please select at least one of the newsletters

Ask a Question


Invalid Input
Invalid Input
Invalid email address
Please type in your question

Masterclass Prospectus Request


Submit the following information to receive the downloadable prospectus instantaneously.

Invalid Input
Invalid Input
Invalid email address
Invalid Input
Invalid Input